Recoiled Stocks in Momentum: Globus Medical (NYSE:GMED), CTI BioPharma (NASDAQ:CTIC)

Globus Medical, Inc. (NYSE:GMED) [Trend Analysis] luring active investment momentum, shares an advance 0.20% to $24.89. Globus Medical, Inc. (GMED) reported that Excelsius GPS, a revolutionary system providing robotic trajectory guidance and navigation, is now CE marked. This platform technology supports both minimally invasive and open orthopedic and neurosurgical procedures, with applications ranging from the cervical spine to the sacroilium, long bones and cranium.

Excelsius GPS seamlessly integrates with Globus Medical implants and instruments and is compatible with pre-operative CT, intra-operative CT and fluoroscopic imaging modalities. The system is designed to minimize radiation exposure, streamline workflow, and reproducibly assist in implant placement. The total volume of 32762 shares held in the session was surprisingly higher than its average volume of 1148.03 shares.

EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at 21.20%, and looking further price to next year’s EPS is 6.36%. While take a short look on price to sales ratio, that was 4.29 and price to earnings ratio of 20.34 attracting passive investors.

Several matter pinch shares of CTI BioPharma Corp. (NASDAQ:CTIC) [Trend Analysis], as shares moving up 4.93% to $4.68 with a share volume of 393123. CTI BioPharma Corp. (CTIC) revealed that the full clinical hold in February 2016 implemented by the U.S. Food and Drug Administration on all clinical trials conducted under the Investigational New Drug or IND application for pacritinib has now been removed.

The Company’s complete response submission included, among other items, final Clinical Study Reports for both PERSIST-1 and 2 trials and a dose-exploration clinical trial protocol that the FDA requested. The stock is going forward its 52-week’s low with 1761.58% and moving down from its 52-week’s high price with -13.81%. To have technical analysis views, liquidity ratio of a company was calculated 1.50 as evaluated with its debt to equity ratio of 1.18. The float short ratio was 0.27%, as compared to sentiment indicator; Short Ratio was 0.78.


About Richard Avery

He is a capital projects manager and process design engineer at a large-cap company. He has renowned MBA degree. Before joining SWR, he was a freelance writer for renounce tech websites. He is currently studying for CFP exam. Interests: Tech stocks, Economic Markets, Blue-chips.

Leave a Reply

Your email address will not be published. Required fields are marked *